| More In New Drug News - American Journal of Hemotology and Oncology |
|
|
American Journal of Hemotology and OncologyRenal impairment (crcl <45ml/min): not recommended. Discontinue if Grade 3 or 4 neurotoxicity occurs, or if any Grade 3 or 4 toxicity occurs after 2 dose ... read more |